KYMR
Kymera TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
KYMR vs peer average
40/100
KYMR vs. peer average (D vs. C)
Grade spread
A 1 · B 2 · C 2 · D 2 · F 3
Graded peers loaded
Coverage
10 graded
91% of tracked
Peer overview
COGT is the first available peer comparator.
Cogent Biosciences is a closer small-cap clinical biotech risk comparator than a business-model match; both trade on pipeline execution rather than commercial cash flow, so trial timing and readout quality matter more than quarterly revenue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
KYMR
Kymera Therapeutics
COGT
Cogent Biosciences
Grade
D
F
Momentum
78
12
Value
41
41
Sentiment
36
0
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs COGT
KYMR / COGT
Grade Position
Below peers
KYMR vs. peer average (D vs. C)
40/100
Momentum
78
KYMRValue
41
KYMRSentiment
36
KYMRRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs KYMR
COGT is the first peer returned for this comparison set.